BlackRock Inc. - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 23 filers reported holding BENITEC BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q1 2022$46,000
-13.2%
19,554
-4.6%
0.00%
Q4 2021$53,000
-25.4%
20,499
+2.6%
0.00%
Q3 2021$71,000
-29.7%
19,974
-16.4%
0.00%
Q2 2021$101,00023,8960.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$1,796,0000.06%
Atom Investors LP 37,335$87,0000.04%
SILVERARC CAPITAL MANAGEMENT, LLC 492,880$57,0000.02%
WealthTrust Axiom LLC 12,950$30,0000.01%
UBS Group AG 347$1,0000.00%
WELLS FARGO & COMPANY/MN 43$00.00%
NORTHERN TRUST CORP 11,813$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,000$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 59,566$139,0000.00%
View complete list of BENITEC BIOPHARMA INC shareholders